BofA analyst Bryan Spillane raised the firm’s price target on Colgate-Palmolive to $85 from $80 and keeps a Neutral rating on the shares. Colgate’s above-consensus Q1 was "a step in the right direction" after weaker gross margins led to mixed Q4 results, the analyst tells investors. The firm’s target now reflects a higher multiple as it argues that multiple expansion is warranted by Colgate’s improved earnings power through premiumization and efficiencies.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on CL:
- Colgate-Palmolive price target raised to $81 from $76 at Wells Fargo
- Colgate-Palmolive price target raised to $92 from $88 at Citi
- Colgate-Palmolive Rises on Q1 Showing
- Unusual call flow in option market yesterday
- Colgate-Palmolive reports Q1 base gross profit margin down 160 bps to 56.9%
Questions or Comments about the article? Write to editor@tipranks.com